ICD10 code of Sacrococcygeal Teratoma and ICD9 code

The ICD-10 code for Sacrococcygeal Teratoma is D38.6 (or more specifically categorized under congenital malformations as Q89.0), while the ICD-9 code historically used is 237.7. Because Sacrococcygeal Teratoma is a complex developmental tumor, clinicians often utilize a combination of codes to accurately capture both the neoplasm and its associated congenital anatomical findings.

What is a Sacrococcygeal Teratoma?

A Sacrococcygeal Teratoma is the most common tumor found in newborns, arising from the sacrococcygeal region (the base of the tailbone). These tumors are germ cell tumors that can be benign or malignant, often requiring prenatal diagnosis via ultrasound to monitor fetal growth and potential heart failure complications. Currently, 40 individuals within the DiseaseMaps community have shared their experiences living with or caring for those affected by Sacrococcygeal Teratoma.

How is Sacrococcygeal Teratoma classified and coded?

Medical coding for Sacrococcygeal Teratoma helps healthcare systems track prevalence and treatment outcomes. While ICD-10 and ICD-9 codes provide a general framework, the clinical classification is often determined by the Altman Classification system, which categorizes the tumor based on its external and internal pelvic extension:

• Type I: Predominantly external with minimal presacral component.


• Type II: External mass with a significant intrapelvic component.


• Type III: External mass with a major pelvic and abdominal extension.


• Type IV: Entirely presacral with no external mass visible.

Is Sacrococcygeal Teratoma hereditary?

In the vast majority of cases, Sacrococcygeal Teratoma occurs sporadically, meaning it is not considered an inherited genetic condition. It is believed to arise from pluripotent cells during early embryonic development. While the condition can be life-altering for families, genetic counseling is often recommended to provide reassurance regarding future pregnancies and to understand the rare instances where familial clustering has been reported in clinical literature.

Next steps

• Consult with a pediatric surgeon or neonatologist specializing in fetal surgery.


• Connect with the 40 members of the DiseaseMaps community who understand the journey of managing a Sacrococcygeal Teratoma diagnosis.


• Schedule follow-up screenings to monitor for potential recurrence, which is a standard protocol for pediatric oncology follow-up.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• American Pediatric Surgical Association (APSA) guidelines on Sacrococcygeal Teratoma


• OMIM (Online Mendelian Inheritance in Man) database